Featured Publication in Focus: Cyld restrains the hyperactivation of synovial fibroblasts in inflammatory arthritis by regulating the TAK1/IKK2 signaling axis

Authors:

Vagelis Rinotas, Kalliopi Iliaki, Lydia Pavlidi, Theodore Meletakos, George Mosialos and Marietta Armaka

 

Institute for Fundamental Biomedical Research, Biomedical Sciences Research Center (BSRC) “Alexander Fleming”, Vari, Greece.

 

nature. Cell Death & Disease Press

 

----------------------

Product referenced:

Catalogue # CIA-MAB-2C

ArthritoMab™ Antibody Cocktail for C57BL/6, TG, 50 mg

 

ABSTRACT

TNF is a potent cytokine known for its involvement in physiology and pathology. In Rheumatoid Arthritis (RA), persistent TNF signals cause aberrant activation of synovial fibroblasts (SFs), the resident cells crucially involved in the inflammatory and destructive responses of the affected synovial membrane. However, the molecular switches that control the pathogenic activation of SFs remain poorly defined. Cyld is a major component of deubiquitination (DUB) machinery regulating the signaling responses towards survival/inflammation and programmed necrosis that induced by cytokines, growth factors and microbial products. Herein, we follow functional genetic approaches to understand how Cyld affects arthritogenic TNF signaling in SFs. We demonstrate that in spontaneous and induced RA models, SF-Cyld DUB deficiency deteriorates arthritic phenotypes due to increased levels of chemokines, adhesion receptors and bone-degrading enzymes generated by mutant SFs. Mechanistically, Cyld serves to restrict the TNF-induced hyperactivation of SFs by limiting Tak1-mediated signaling, and, therefore, leading to supervised NF-κB and JNK activity. However, Cyld is not critically involved in the regulation of TNF-induced death of SFs. Our results identify SF-Cyld as a regulator of TNF-mediated arthritis and inform the signaling landscape underpinning the SF responses.

 

To continue reading and to download the publication: